Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-10-15 Purchase(A) |
2024-10-22 5:31 pm |
Camp4 Therapeutics Corp | CAMP | Polaris Management Co. VII L.L.C. Polaris Partners VII L.P. Polaris Entrepreneurs' Fund VII L.P. Polaris Partners X L.P. Polaris Partners GP X L.L.C. SCHULMAN AMY W Chee Brian 10% Owner |
909,090 | $11 | $9,999,990 | 909,090 (Indirect) |
View |
2024-10-15 Purchase |
2024-10-17 6:34 pm |
Camp4 Therapeutics Corp | CAMP | Northpond Ventures II GP LLC Northpond Ventures II LP Northpond Ventures GP LLC Northpond Ventures LP Northpond Ventures III GP LLC Northpond Ventures III LP Rubin Michael P. 10% Owner |
763,636 | $11 | $8,399,996 | 763,636 (Indirect) |
View |
2024-10-15 Purchase |
2024-10-17 5:05 pm |
Camp4 Therapeutics Corp | CAMP | AH Equity Partners Bio I L.L.C. AH Bio Fund I L.P. AH Equity Partners Bio IV L.L.C. AH Bio Fund IV L.P. Andreessen Marc L HOROWITZ BENJAMIN A 10% Owner |
727,272 | $11 | $7,999,992 | 545,454 (Indirect) |
View |
2024-10-15 Purchase |
2024-10-17 4:15 pm |
Camp4 Therapeutics Corp | CAMP | Enavate Sciences GP LLC Everest Aggregator LP 10% Owner |
1,363,636 | $11 | $14,999,996 | 3,785,802 (Indirect) |
View |
2024-10-15 Purchase |
2024-10-15 6:00 pm |
Camp4 Therapeutics Corp | CAMP | Polaris Management Co. VII L.L.C. Polaris Partners VII L.P. Polaris Entrepreneurs' Fund VII L.P. Polaris Partners X L.P. Polaris Partners GP X L.L.C. SCHULMAN AMY W 10% Owner |
909,090 | $11 | $9,999,990 | 909,090 (Indirect) |
View |
2024-10-15 Purchase |
2024-10-15 5:56 pm |
Camp4 Therapeutics Corp | CAMP | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. PARMAR KUSH 10% Owner |
909,090 | $11 | $9,999,990 | 2,625,145 (Indirect) |
View |
2024-10-15 Purchase |
2024-10-15 5:49 pm |
Camp4 Therapeutics Corp | CAMP | Nashat Amir Director 10% Owner |
909,090 | $11 | $9,999,990 | 909,090 (Indirect) |
View |
2024-10-15 Purchase |
2024-10-15 5:48 pm |
Camp4 Therapeutics Corp | CAMP | Schwab Andrew J. Director 10% Owner |
909,090 | $11 | $9,999,990 | 2,625,145 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership(A) |
2025-04-11 4:06 pm |
N/A N/A |
Camp4 Therapeutics Corp | CAMP | WILLIAMS DOUGLAS E Director |
0 | $0 | 2,501 (Direct) |
View |
2025-04-01 Option Award |
2025-04-03 4:09 pm |
N/A 2035-03-31 |
Camp4 Therapeutics Corp | CAMP | Bumcrot David Chief Scientific Officer |
45,000 | $0 | 45,000 (Direct) |
View |
2025-04-01 Option Award |
2025-04-03 4:08 pm |
N/A 2035-03-31 |
Camp4 Therapeutics Corp | CAMP | Maricich Yuri Chief Medical Officer |
80,000 | $0 | 80,000 (Direct) |
View |
2025-04-01 Option Award |
2025-04-03 4:07 pm |
N/A 2035-03-31 |
Camp4 Therapeutics Corp | CAMP | Gold Kelly Chief Financial Officer |
80,000 | $0 | 80,000 (Direct) |
View |
2025-04-01 Option Award |
2025-04-03 4:06 pm |
N/A 2035-03-31 |
Camp4 Therapeutics Corp | CAMP | Mandel-Brehm Josh Chief Executive Officer |
160,000 | $0 | 160,000 (Direct) |
View |
2025-03-17 Option Award |
2025-03-19 4:09 pm |
N/A 2035-03-16 |
Camp4 Therapeutics Corp | CAMP | WILLIAMS DOUGLAS E Director |
17,787 | $0 | 17,787 (Direct) |
View |
2025-03-17 Option Award |
2025-03-19 4:07 pm |
N/A 2035-03-16 |
Camp4 Therapeutics Corp | CAMP | Stewart Murray Director |
17,787 | $0 | 17,787 (Direct) |
View |
2024-10-15 Conversion(A) |
2024-10-22 5:31 pm |
N/A N/A |
Camp4 Therapeutics Corp | CAMP | Polaris Management Co. VII L.L.C. Polaris Partners VII L.P. Polaris Entrepreneurs' Fund VII L.P. Polaris Partners X L.P. Polaris Partners GP X L.L.C. SCHULMAN AMY W Chee Brian 10% Owner |
20,962,046 | $0 | 909,090 (Indirect) |
View |
Ownership(A) |
2024-10-22 5:05 pm |
N/A N/A |
Camp4 Therapeutics Corp | CAMP | Polaris Partners GP X L.L.C. Polaris Partners X L.P. SCHULMAN AMY W Chee Brian 10% Owner |
0 | $0 | 909,090 (Indirect) |
View |
2024-10-15 Conversion |
2024-10-17 6:34 pm |
N/A N/A |
Camp4 Therapeutics Corp | CAMP | Northpond Ventures II GP LLC Northpond Ventures II LP Northpond Ventures GP LLC Northpond Ventures LP Northpond Ventures III GP LLC Northpond Ventures III LP Rubin Michael P. 10% Owner |
18,013,535 | $0 | 763,636 (Indirect) |
View |
2024-10-15 Conversion |
2024-10-17 5:05 pm |
N/A N/A |
Camp4 Therapeutics Corp | CAMP | AH Equity Partners Bio I L.L.C. AH Bio Fund I L.P. AH Equity Partners Bio IV L.L.C. AH Bio Fund IV L.P. Andreessen Marc L HOROWITZ BENJAMIN A 10% Owner |
17,078,542 | $0 | 545,454 (Indirect) |
View |
2024-10-15 Conversion |
2024-10-17 4:15 pm |
N/A N/A |
Camp4 Therapeutics Corp | CAMP | Enavate Sciences GP LLC Everest Aggregator LP 10% Owner |
29,588,696 | $0 | 3,785,802 (Indirect) |
View |
2024-10-15 Conversion |
2024-10-15 6:00 pm |
N/A N/A |
Camp4 Therapeutics Corp | CAMP | Polaris Management Co. VII L.L.C. Polaris Partners VII L.P. Polaris Entrepreneurs' Fund VII L.P. Polaris Partners X L.P. Polaris Partners GP X L.L.C. SCHULMAN AMY W 10% Owner |
20,962,046 | $0 | 909,090 (Indirect) |
View |
2024-10-15 Conversion |
2024-10-15 5:56 pm |
N/A N/A |
Camp4 Therapeutics Corp | CAMP | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. PARMAR KUSH 10% Owner |
24,661,577 | $0 | 2,625,145 (Indirect) |
View |
2024-10-15 Conversion |
2024-10-15 5:49 pm |
N/A N/A |
Camp4 Therapeutics Corp | CAMP | Nashat Amir Director 10% Owner |
20,962,046 | $0 | 909,090 (Indirect) |
View |
2024-10-15 Conversion |
2024-10-15 5:48 pm |
N/A N/A |
Camp4 Therapeutics Corp | CAMP | Schwab Andrew J. Director 10% Owner |
24,661,577 | $0 | 2,625,145 (Indirect) |
View |
2024-10-15 Conversion |
2024-10-15 5:47 pm |
N/A N/A |
Camp4 Therapeutics Corp | CAMP | Holtzman Steven H Director |
108,931 | $0 | 108,946 (Direct) |
View |
2024-10-15 Conversion |
2024-10-15 5:46 pm |
N/A N/A |
Camp4 Therapeutics Corp | CAMP | Young Richard A Director |
108,931 | $0 | 154,859 (Direct) |
View |
2024-10-15 Conversion |
2024-10-15 5:45 pm |
N/A N/A |
Camp4 Therapeutics Corp | CAMP | Mandel-Brehm Josh Chief Executive Officer |
7,396 | $0 | 272,357 (Direct) |
View |
Ownership |
2024-10-15 5:32 pm |
N/A N/A |
Camp4 Therapeutics Corp | CAMP | Polaris Partners GP X L.L.C. Polaris Partners X L.P. SCHULMAN AMY W 10% Owner |
0 | $0 | 909,090 (Indirect) |
View |
Ownership |
2024-10-10 9:34 pm |
N/A N/A |
Camp4 Therapeutics Corp | CAMP | Polaris Management Co. VII L.L.C. Polaris Partners VII L.P. Polaris Entrepreneurs' Fund VII L.P. 10% Owner |
0 | $0 | 1,715,972 (Indirect) |
View |
Ownership |
2024-10-10 9:22 pm |
N/A N/A |
Camp4 Therapeutics Corp | CAMP | Enavate Sciences GP LLC Everest Aggregator LP 10% Owner |
0 | $0 | 2,422,166 (Indirect) |
View |
Ownership |
2024-10-10 9:20 pm |
N/A N/A |
Camp4 Therapeutics Corp | CAMP | Northpond Ventures II GP LLC Northpond Ventures II LP Northpond Ventures GP LLC Northpond Ventures LP Rubin Michael P. 10% Owner |
0 | $0 | 1,474,608 (Indirect) |
View |
Ownership |
2024-10-10 9:18 pm |
N/A N/A |
Camp4 Therapeutics Corp | CAMP | AH Equity Partners Bio I L.L.C. AH Bio Fund I L.P. Andreessen Marc L HOROWITZ BENJAMIN A 10% Owner |
0 | $0 | 1,398,067 (Indirect) |
View |
Ownership |
2024-10-10 9:15 pm |
N/A N/A |
Camp4 Therapeutics Corp | CAMP | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. PARMAR KUSH 10% Owner |
0 | $0 | 2,018,825 (Indirect) |
View |
Ownership |
2024-10-10 9:06 pm |
N/A 2034-08-19 |
Camp4 Therapeutics Corp | CAMP | Maricich Yuri Chief Medical Officer |
0 | $0 | 132,886 (Direct) |
View |
Ownership |
2024-10-10 9:06 pm |
N/A N/A |
Camp4 Therapeutics Corp | CAMP | Mandel-Brehm Josh Chief Executive Officer |
0 | $0 | 787,779 (Direct) |
View |
Ownership |
2024-10-10 9:06 pm |
N/A N/A |
Camp4 Therapeutics Corp | CAMP | Gold Kelly Chief Financial Officer |
0 | $0 | 224,366 (Direct) |
View |
Ownership |
2024-10-10 9:05 pm |
N/A N/A |
Camp4 Therapeutics Corp | CAMP | Nashat Amir Director 10% Owner |
0 | $0 | 1,715,972 (Indirect) |
View |
Ownership |
2024-10-10 9:05 pm |
N/A N/A |
Camp4 Therapeutics Corp | CAMP | Schwab Andrew J. Director 10% Owner |
0 | $0 | 2,018,825 (Indirect) |
View |
Ownership |
2024-10-10 9:03 pm |
N/A N/A |
Camp4 Therapeutics Corp | CAMP | Bumcrot David Chief Scientific Officer |
0 | $0 | 179,778 (Direct) |
View |
Ownership |
2024-10-10 9:03 pm |
N/A N/A |
Camp4 Therapeutics Corp | CAMP | Holtzman Steven H Director |
0 | $0 | 196,517 (Direct) |
View |
Ownership |
2024-10-10 9:02 pm |
N/A N/A |
Camp4 Therapeutics Corp | CAMP | Higgins Michael J Director |
0 | $0 | 44,412 (Direct) |
View |
Ownership |
2024-10-10 9:02 pm |
N/A N/A |
Camp4 Therapeutics Corp | CAMP | Ragan Paula Director |
0 | $0 | 34,488 (Direct) |
View |
Ownership |
2024-10-10 9:01 pm |
N/A N/A |
Camp4 Therapeutics Corp | CAMP | Thadhani Ravi I. Director |
0 | $0 | 31,270 (Direct) |
View |
Ownership |
2024-10-10 9:01 pm |
N/A N/A |
Camp4 Therapeutics Corp | CAMP | Young Richard A Director |
0 | $0 | 255,230 (Direct) |
View |